Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.

Accepted 2021-11-22 00:00:00 ET · period of report 2021-11-18 · accession 0001209191-21-066254 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2021-11-22	2021-11-18	RXRX	Borgeson Blake	Dir	S - Sale	$18.91	-9,625	7.68M	-0.1%	-$182.0K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2021-11-18	S	D	1,900	$18.32	7,687,191	D	—	—	(F2) The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $17.86 to $18.835 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
2	Common	Class A Common Stock	2021-11-18	S	D	7,725	$19.05	7,679,466	D	—	—	(F3) The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $18.87 to $19.44 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.